CoChat

Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study

Open access
Thielemans, Laurence, Gornsawun, Gornpan, Hanboonkunupakarn, Borimas, Paw, Moo Kho, Porn, Pen, Moo, Paw Khu, Van Overmeire, Bart, Proux, Stephane, Nosten, François, McGready, Rose, Carrara, Verena I., Bancone, Germana · 2018 · Wellcome Open Research
Cited by 49

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an inherited enzymatic disorder associated with severe neonatal hyperbilirubinemia and acute haemolysis after exposure to certain drugs or infections. The disorder can be diagnosed phenotypically with a fluorescent spot test (FST), which is a simple test that requires training and basic laboratory equipment. This study aimed to assess the diagnostic performances of the FST used on umbilical cord blood by locally-trained staff and to compare test results of the neonates at birth with the results after one month of age. Methods : We conducted a cohort study on newborns at the Shoklo Malaria Research Unit, along the Thai-Myanmar border between January 2015 and May 2016. The FST was performed at birth on the umbilical cord blood by locally-trained staff and quality controlled by specialised technicians at the central laboratory. The FST was repeated after one month of age. Genotyping for common local G6PD mutations was carried out for all discrepant results. Results: FST was performed on 1521 umbilical cord blood samples. Quality control and genotyping revealed 10 misdiagnoses. After quality control, 10.7% of the males (84/786) and 1.2% of the females (9/735) were phenotypically G6PD deficient at birth. The FST repeated at one month of age or later diagnosed 8 additional G6PD deficient infants who were phenotypically normal at birth. Conclusions : This study shows the short-comings of the G6PD FST in neonatal routine screening and highlights the importance of training and quality control. A more conservative interpretation of the FST in male newborns could increase the diagnostic performances. Quantitative point-of-care tests might show higher sensitivity and specificity for diagnosis of G6PD deficiency on umbilical cord blood and should be investigated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.12688/wellcomeopenres.13373.1

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. R Howes, 2012, G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map., PLoS Med., 9, e1001339, 10.1371/journal.pmed.1001339 · DOI · Paper page
  2. Z Rostami-Far, 2016, Glucose-6-phosphate dehydrogenase deficiency (G6PD) as a risk factor of male neonatal sepsis., J Med Life., 9, 34-8
  3. J Watchko, 2013, Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?, J Perinatol., 33, 499-504, 10.1038/jp.2013.14 · DOI
  4. M Maisels, 2009, Hyperbilirubinemia in the newborn infant > or =35 weeks’ gestation: an update with clarifications., Pediatrics., 124, 1193-8, 10.1542/peds.2009-0329 · DOI · Paper page
  5. M Kaplan, 1999, Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes., Pediatrics., 104, 68-74, 10.1542/peds.104.1.68 · doi:10.1542/peds.104.1.68
  6. Y Arain, 2014, Prevention of kernicterus in South Asia: Role of neonatal G6PD deficiency and its identification., Indian J Pediatr., 81, 599-607, 10.1007/s12098-014-1410-y · DOI
  7. 1989, Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group., Bull World Health Organ., 67, 601-11
  8. E Beutler, 2015, Special Modifications of the Fluorescent screening method for Glucose-6-Phosphate Dehydrogenase Deficiency., Fluoresc Screen Methods., 32, 816-8
  9. D Nantakomol, 2013, Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency., Malar J., 12, 289, 10.1186/1475-2875-12-289 · DOI
  10. N Oo, 2016, Validation of G6PD point-of-care tests among healthy volunteers in Yangon, Myanmar., PLoS One., 11, e0152304, 10.1371/journal.pone.0152304 · DOI · Paper page
  11. G Bancone, 2015, Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests., Am J Trop Med Hyg., 92, 818-24, 10.4269/ajtmh.14-0696 · DOI · Paper page
  12. A Roca-Feltrer, 2014, Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia., PLoS One., 9, e116143, 10.1371/journal.pone.0116143 · DOI · Paper page
  13. G Bancone, 2017, Prevalences of inherited red blood cell disorders in pregnant women of different ethnicities living along the Thailand-Myanmar border [version 2; referees: 2 approved]., Wellcome Open Res., 2, 72, 10.12688/wellcomeopenres.12338.2 · DOI · Paper page
  14. S AlSaif, 2017, Screening for glucose-6-phosphate dehydrogenase deficiency in neonates: a comparison between cord and peripheral blood samples., BMC Pediatr., 17, 159, 10.1186/s12887-017-0912-y · DOI
  15. S Travis, 1980, Red cell metabolic alterations in postnatal life in term infants: glycolytic enzymes and glucose-6-phosphate dehydrogenase., Pediatr Res., 14, 1349-52, 10.1203/00006450-198012000-00016 · doi:10.1203/00006450-198012000-00016
  16. M Kaplan, 2005, Glucose-6-phosphate dehydrogenase activity in term and near-term, male African American neonates., Clin Chim Acta., 355, 113-7, 10.1016/j.cccn.2004.12.008 · doi:10.1016/j.cccn.2004.12.008
  17. N Cohan, 2010, The efficacy of a neonatal screening programme in decreasing the hospitalization rate of patients with G6PD deficiency in southern Iran., J Med Screen., 17, 66-7, 10.1258/jms.2010.009105 · DOI
  18. M Kosaryan, 2014, Why does the Iranian national program of screening newborns for G6PD enzyme deficiency miss a large number of affected infants?, Pediatr Hematol Oncol., 31, 95-100, 10.3109/08880018.2013.871613 · DOI
  19. L Thielemans, 2017, Neonatal Hyperbilirubinemia in a Marginalized Population on the Thai-Myanmar Border: a study protocol., BMC Pediatr., 17, 32, 10.1186/s12887-017-0798-8 · DOI
  20. K Plewes, 2017, Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria., Malar J., 16, 134, 10.1186/s12936-017-1788-x · DOI
  21. M Kosaryan, 2014, Why does the Iranian national program of screening newborns for G6PD enzyme deficiency miss a large number of affected infants?, Pediatr Hematol Oncol., 31, 95-100, 10.3109/08880018.2013.871613 · DOI
  22. J Jiang, 2014, Screening and prevention of neonatal glucose 6-phosphate dehydrogenase deficiency in Guangzhou, China., Genet Mol Res., 13, 4272-9, 10.4238/2014.June.9.13 · doi:10.4238/2014.june.9.13
  23. M Lakomek, 1989, On the diagnosis of erythrocyte enzyme defects in the presence of high reticulocyte counts., Br J Haematol., 72, 445-51, 10.1111/j.1365-2141.1989.tb07730.x · doi:10.1111/j.1365-2141.1989.tb07730.x
  24. R Christensen, 2016, Reference intervals for reticulocyte parameters of infants during their first 90 days after birth., J Perinatol., 36, 61-6, 10.1038/jp.2015.140 · doi:10.1038/jp.2015.140
  25. G Paterakis, 1993, Flow-cytometric analysis of reticulocytes in normal cord blood., Acta Haematol., 90, 182-5, 10.1159/000204454 · DOI · Paper page
  26. M Kaplan, 2015, Parental education and the WHO neonatal G-6-PD screening program: a quarter century later., J Perinatol., 35, 779-84, 10.1038/jp.2015.77 · DOI
  27. F Keihanian, 2017, Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period., Int J Lab Hematol., 39, 251-60, 10.1111/ijlh.12618 · DOI
  28. N Algur, 2012, Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype., J Pediatr., 161, 197-200, 10.1016/j.jpeds.2012.02.045 · DOI
  29. M De Niz, 2013, Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda., Malar J., 12, 210, 10.1186/1475-2875-12-210 · DOI
  30. V Bhutani, 2015, Point-of-Care Quantitative Measure of Glucose-6-Phosphate Dehydrogenase Enzyme Deficiency., Pediatrics., 136, e1268-75, 10.1542/peds.2015-2122 · DOI
  31. B Ley, 2017, Methods for the field evaluation of quantitative G6PD diagnostics: a review., Malar J., 16, 361, 10.1186/s12936-017-2017-3 · DOI · Paper page

Cited by

See all 49

Metadata

Authors
Thielemans, L., Gornsawun, G., Hanboonkunupakarn, B., Paw, M. K., Porn, P., Moo, P. K., Van Overmeire, B., Proux, S., Nosten, F., McGready, R., Carrara, V. I., & Bancone, G.
Venue
Wellcome Open Research
Published
2018-01-02
Volume
3
Pages
1
ISSN
2398-502X (ISSN-L)
OpenAlex
W2781635256
Cited by
49
References
5
FWCI
4.66
Type
journal article
Language
en
Open access
gold
Licence
creativecommons.org/licenses/by/4.0/ (tdm)
Funders
  • Wellcome Trust (089179, 106698)
  • The Belgian Kids' Fund for Pediatric Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.